世界中医药2024,Vol.19Issue(17) :2636-2640,2646.DOI:10.3969/j.issn.1673-7202.2024.17.016

调经促孕方治疗肾虚型多囊卵巢综合征不孕合并睡眠障碍的临床疗效

Clinical Efficacy of Tiaojing Cuyun Formula in the Treatment of Kidney Deficiency-induced Polycystic Ovary Syndrome Infertility with Sleep Disorders

杨佩诗 董莉 黄宏丽 夏艳秋
世界中医药2024,Vol.19Issue(17) :2636-2640,2646.DOI:10.3969/j.issn.1673-7202.2024.17.016

调经促孕方治疗肾虚型多囊卵巢综合征不孕合并睡眠障碍的临床疗效

Clinical Efficacy of Tiaojing Cuyun Formula in the Treatment of Kidney Deficiency-induced Polycystic Ovary Syndrome Infertility with Sleep Disorders

杨佩诗 1董莉 2黄宏丽 2夏艳秋2
扫码查看

作者信息

  • 1. 上海中医药大学,上海,201203
  • 2. 上海中医药大学附属岳阳中西医结合医院,上海,200437
  • 折叠

摘要

目的:观察调经促孕方治疗肾虚型多囊卵巢综合征(PCOS)不孕合并睡眠障碍的临床疗效.方法:选取2021年10月至2022年11月于上海中医药大学附属岳阳中西医结合医院妇科门诊就诊的PCOS不孕症患者98例作为研究对象.采用随机数表法将患者分为观察组和对照组,排除脱落9例,最终观察组45例,对照组44例.观察组给予调经促孕方治疗,对照组以来曲唑治疗.2组患者均于经期第5天开始服药,共治疗3个月经周期,并对妊娠患者随访至妊娠8周.对比2组患者妊娠率、优势卵泡排出率、卵泡黄素化率、排卵期子宫内膜厚度、基础性激素水平、匹兹堡睡眠量表(PSQI)评分、中医证候评分.结果:2组患者妊娠率、临床妊娠率差异无统计学意义(37.78%对比25%,P>0.05;88.24%对比54.55%,P>0.05).2组患者优势卵泡排出率差异无统计学意义(57.48%对比65.89%,P>0.05).观察组卵泡黄素化率低于对照组(8.66%对比17.83%,P<0.05).治疗后,观察组排卵期子宫内膜厚度增加程度优于对照组(P<0.05).治疗后观察组黄体生成素(LH)、LH/FSH和睾酮(T)下降程度低于对照组(P<0.05).治疗后观察组PSQI评分、中医证候评分均低于对照组(P<0.05).结论:调经促孕方能有效治疗肾虚型PCOS不孕症,提高妊娠率和优势卵泡排出率,同时减少卵泡黄素化率,增加排卵期子宫内膜厚度,降低基础LH、LH/FSH和T水平;调经促孕方可通过改善PCOS不孕症患者的睡眠质量和肾虚证临床症状,提高生命质量.

Abstract

Objective:To observe the clinical efficacy of Tiaojing Cuyun Formula in treating infertility due to kidney deficiency type polycystic ovary syndrome(PCOS)complicated by sleep disorders.Methods:A total of 98 PCOS infertility patients visited the gynecology outpatient department of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated with Shanghai University of Traditional Chinese Medicine from October 2021 to November 2022 were enrolled and randomly divided into an observation group and a control group using a random number table,with 9 dropouts,resulting in 45 patients in the observation group and 44 in the control group.The observation group received Tiaojing Cuyun Formula,while the control group was treated with Letrozole.Both groups began treatment on the fifth day of their menstrual cycle and were treated for three menstrual cycles,with fol-low-up until 8 weeks of pregnancy for those who conceived.The pregnancy rate,dominant follicle ovulation rate,luteinization rate,endometrial thickness during ovulation,baseline hormone levels,Pittsburgh Sleep Quality Index(PSQI)scores,and traditional Chi-nese medicine(TCM)syndrome scores were compared between the two groups.Results:There was no significant difference in the overall pregnancy rate(37.78%vs.25%,P>0.05)and clinical pregnancy rate(88.24%vs.54.55%,P>0.05)between the two groups.The dominant follicle ovulation rate also showed no significant difference(57.48%vs.65.89%,P>0.05).The lutein-ization rate in the observation group was lower than that in the control group(8.66%vs.17.83%,P<0.05).The increase in en-dometrial thickness during ovulation in the observation group was superior to that in the control group(P<0.05).After treatment,the levels of luteinizing hormone(LH),LH/follicle-stimulating hormone(FSH)ratio,and testosterone(T)in the observation group decreased to a lesser extent than the control group(P<0.05).The PSQI scores and TCM syndrome scores in the observation group were both lower than those in the control group after treatment(P<0.05).Conclusion:Tiaojing Cuyun Formula can effectively treat kidney deficiency type PCOS infertility,improve pregnancy and dominant follicle ovulation rates,reduce luteinization rates,increase endometrial thickness during ovulation,and lower baseline LH,LH/FSH ratio,and T levels.Additionally,this formula can enhance sleep quality and alleviate clinical symptoms of kidney deficiency in PCOS infertility patients,thereby improving quality of life.

关键词

多囊卵巢综合征/不孕/睡眠障碍/调经促孕方/睡眠质量/肾气虚证/生殖/来曲唑

Key words

Polycystic ovary syndrome/Infertility/Sleep disorder/Tiaojin Cuyun Formula/Sleep quality/Kidney deficiency syn-drome/Reproductive science/Letrozole

引用本文复制引用

出版年

2024
世界中医药
世界中医药学会联合会

世界中医药

CSTPCDCHSSCD北大核心
影响因子:1.266
ISSN:1673-7202
段落导航相关论文